# TheraPanacea

Source: https://onco.cc/companies/therapanacea/  
OnCo record `therapanacea` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

TheraPanacea is a Paris AI company whose ART-Plan does auto-contouring and synthetic CT in radiotherapy.

## Summary

TheraPanacea, based in Paris, is an AI company whose ART-Plan software performs auto-contouring and synthetic CT generation in radiotherapy. Its ART-Plan Annotate and Adapt modules are CE-marked and FDA-cleared, and the company grew out of academic work at CentraleSupélec. OnCo links it to AI auto-contouring and adaptive planning. Whether synthetic CT from MR can remove the planning scan altogether, and whether adaptive planning tools change outcomes rather than workflow, are the open questions. The auto-contouring technology page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Paris
- Type: ai-software
- Website: https://www.therapanacea.eu

## Sources

- Official website: https://www.therapanacea.eu

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Radiation Therapy](https://onco.cc/fronts/radiation/)
- technologies: [AI auto-contouring and adaptive planning](https://onco.cc/technologies/auto-contouring-ai/)
- roadmaps: [AI in oncology roadmap: pattern readers → foundation models → agents in the workflow](https://onco.cc/roadmaps/ai-oncology-roadmap/), [Radiotherapy roadmap: X-rays → shaped beams → fewer fractions, particles and FLASH](https://onco.cc/roadmaps/radiation-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/therapanacea.json